The importance of patient-reported outcomes in clinical trials and strategies for future optimization
Year: 2018
Type: review
Abstract: Patient-reported outcomes (PROs) can be included in clinical trials as primary or secondary endpoints and are increasingly recognized by regulators, clinicians, and patients as valuable tools to collect patient-centered data. PROs provide unique information on the impact of a medical condition and its treatment from the patient's perspective; therefore, PROs can be included in clinical trials to ensure the impact of a trial intervention is comprehensively assessed. This review first discusses examples of how PRO endpoints have added value to clinical trial interpretation. Second, it describes the problems with current practices in designing, implementing, and reporting PRO studies, and how these problems may be addressed by complying with guidance for protocol development, selecting appropriate PRO measures to match clinically motivated PRO hypotheses, minimizing the rates of avoidable missing PRO data, analyzing and interpreting PRO data, and transparently reporting PRO findings.
Source: Patient Related Outcome Measures
DOI: 10.2147/prom.s156279
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $2,320
Funders: University Hospitals Birmingham NHS Foundation Trust, Australian Government, National Institute for Health and Care Research, University of Birmingham, Cancer Australia, Surgical Reconstruction and Microbiology Research Centre, National Health and Medical Research Council, Birmingham Biomedical Research Centre
OpenAlex ID: W2899320385
